Publications

Export 7092 results:
Sort by: Author [ Title  (Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S [T] U V W X Y Z   [Show ALL]
A
Kwak, Y., S. Nam, M. Akçakaya, T. A. Basha, B. Goddu, W. J. Manning, V. Tarokh, and R. Nezafat, "Accelerated aortic flow assessment with compressed sensing with and without use of the sparsity of the complex difference image", Magnetic resonance in medicine, vol. 70, no. 3, pp. 851–858, 2013. Abstract
n/a
Mikolajczak, A., N. A. Sallam, R. D. Singh, T. B. Scheidl, E. J. Walsh, S. Larion, C. Huang, and J. A. Thompson, "Accelerated developmental adipogenesis programs adipose tissue dysfunction and cardiometabolic risk in offspring born to dams with metabolic dysfunction", Am J Physiol Endocrinol Metab, vol. 321, issue 5, pp. E581-E591, 2021.
Parlos, A. G., B. Fernandez, A. F. Atiya, J. Muthusami, and W. K. Tsai, "An accelerated learning algorithm for multilayer perceptron networks", IEEE Transactions on Neural Networks, vol. 5, pp. 493–497, 1994. Abstract
n/a
Parlos, A. G., B. Fernandez, A. F. Atiya, J. Muthusami, and W. K. Tsai, "An accelerated learning algorithm for multilayer perceptron networks", IEEE Transactions on Neural Networks, vol. 5, pp. 493–497, 1994. Abstract
n/a
Atiya, A., A. Parlos, J. Muthusami, B. Fernandez, and W. Tsai, "Accelerated learning in multilayer networks", International Symposium on Neural Networks, 1992. Abstract
n/a
Taha, S., and H. Mostafa, "Accelerated Software Implementation of Authenticated Encryption Stream Ciphers for High Speed Applications ", IEEE International Conference on Microelectronics (ICM 2019), Cairo, Egypt, In Press.
Alfaar, A. S., M. S. Bakry, M. Kamal, S. Ezzat, I. Zaky, H. Taha, A. Ismail, and S. Abouelnaga, "Accelerating Innovation in Outcomes and Quality of Care Research Through Integration of Clinical Databases; Pediatric Oncology Experience in Egypt", American Society of Clinical Oncology, Chicago, ASCO - JCO, 2014. Abstract

Background: Children’s Cancer Hospital -Egypt was established to serve as the country major referral center. Within 6 years the hospital has received 13,865 patients with cancer among 19,744 screened ones. With this rapidly growing number the hospital looked for developing a reliable method for examining the quality of care and supporting health services research as an emerging field in the country. The aim of this paper is to describe the role of integrating several databases in providing a 360 view for healthcare picture. Methods: We have developed an online cancer registry database using RedCap data capture system to gather patients data from different sources. This database was integrated with the electronic medical records to share new patients data instantaneously. Two nurses were trained to curate the database daily and act as human quality control gateway. Cancer registry provided data about 19,927 patients were examined between 2007 and 2013. The second aspect was provided by digitizing and Optical Character Recognition of 12,573 pathology paper-based reports. Pathology reports were analysed electronically to extract dates, initial and final diagnoses, gross and microscopic pictures and markers used for diagnosis. A third aspect was added to the model by mining Radiology Information System database to extract 258,632 studies for all patients. Radiological studies were organized to show the type of investigation, time needed and outcome. Results: A unified comprehensive new database was developed showing uncountable number of quality of care indices and correlations between different initial and final timepoints. Those indicators included delay of diagnosis, reporting and difference in outcomes correlated with epidemiological aspects. The time used to develop this database was two weeks in the first time. A standard operating procedures was developed to decrease time during future updates. Conclusions: Accelerated pathway to research can be acquired in any settings including unprivileged low-middle income countries via structured reporting, integration between different databases and using simple information technology skills.

Sakr, F. Z., M. Taher, A. M. Ei-Bialy, and A. M. Wahba, "Accelerating Iris Recognition algorithms on GPUs", Biomedical Engineering Conference (CIBEC), 2012 Cairo International: IEEE, pp. 73–76, 2012. Abstract
n/a
Hady, A. A., A. Tawfic, and etc, "ACCELERATION AND PARTICLE FIELD INTERACTIONS OF COSMIC RAYS II", Physics International, vol. 4, issue 1, pp. 29-36, 2013. new_paper_2013with_tawfic-.pdf
Tawfik, A., A. Saleh, M. T. Ghoneim, and A. A. Hady, "Acceleration and Particle Field Interactions of Cosmic Rays: Formalism", Physics International, 2012. Abstract

The acceleration of ultra high energy cosmic rays is conjectured to occur through various interactions with the electromagnetic fields in different astrophysical objects, like magnetic matter clumps, besides the well-known shock and stochastic Fermi mechanisms. It is apparent that the latter are not depending on the particle's charge, quantitatively. Based on this model, a considerable portion of the dynamics, that derives a charged particle parallel to a magnetic field and under the influence of a force, is assumed to be composed of an acceleration by a non- magnetic force and a gyromotion along direction, plus drifts in the direction of The model and its formalism are introduced. Various examples for drift motions and accelerating forces are suggested. The formalism is given in a non-relativistic version. Obviously, the translation into the relativistic version is standard. In a forthcoming work, a quantitative estimation of the energy gained by charged cosmic rays in various astrophysical objects will be evaluated.

Hady, A. A., A. Tawfic, and etc, "ACCELERATION AND PARTICLE FIELD INTERACTIONS OF COSMIC RAYS: FORMALISM", Physics Internationa, vol. 3, issue 2, pp. 64-73, 2012. my_paper_with_tawfic-june_2013.pdf
El Kassas, M., M. Alboraie, D. Omran, M. Salaheldin, M. N. Wifi, M. Elbadry, adel el tahan, S. Ezzat, E. Moaz, A. M. Farid, et al., "An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens", Expert Review of Gastroenterology & Hepatology, vol. 12, issue 12, pp. 1265-1272, 2018. single_centre_paper.pdf
El Kassas, M., M. Alboraie, D. Omran, M. Salaheldin, M. N. Wifi, M. Elbadry, adel el tahan, S. Ezzat, E. Moaz, A. M. Farid, et al., "An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.", Expert review of gastroenterology & hepatology, pp. 1-8, 2018 May 24. Abstract

BACKGROUND: A large Egyptian treatment program for HCV was launched in2014 after the introduction of direct-acting antiviral agents (DAAs). This program depended mainly on establishing specialized independent centres for HCV treatment. These centres represent the major strengths in the Egyptian model of care, as they provide integrated care for HCV patients and have enabled Egypt to treat more than one million patients in 3 years. The New Cairo Viral Hepatitis Treatment Center (NCVHTC) is an example of these specialized centres.

METHODS: The Egyptian experience in the management of HCV was evaluated by analysing the data of real-life HCV management in the NCVHTC from 2014 to 2017. Results of different treatment regimens in addition to their strengths, limitations and areas for improvement are discussed in this report.

RESULTS: A total of 7042 HCV patients have been evaluated for treatment in the NCVHTC. Among them, 5517 patients received treatment by seven different DAA regimens with excellent results.

CONCLUSIONS: All regimens were highly effective at treating HCV in a real-life setting, apart from SOF/RBV, which was the least effective. A nationwide screening program and enhancing the follow-up of treated patients are the main missing pillars in the Egyptian model.

El Kassas, M., M. Alboraie, D. Omran, M. Salaheldin, M. N. Wifi, M. Elbadry, adel el tahan, S. Ezzat, E. Moaz, A. M. Farid, et al., "An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.", Expert review of gastroenterology & hepatology, pp. 1-8, 2018 May 24. Abstract

BACKGROUND: A large Egyptian treatment program for HCV was launched in2014 after the introduction of direct-acting antiviral agents (DAAs). This program depended mainly on establishing specialized independent centres for HCV treatment. These centres represent the major strengths in the Egyptian model of care, as they provide integrated care for HCV patients and have enabled Egypt to treat more than one million patients in 3 years. The New Cairo Viral Hepatitis Treatment Center (NCVHTC) is an example of these specialized centres.

METHODS: The Egyptian experience in the management of HCV was evaluated by analysing the data of real-life HCV management in the NCVHTC from 2014 to 2017. Results of different treatment regimens in addition to their strengths, limitations and areas for improvement are discussed in this report.

RESULTS: A total of 7042 HCV patients have been evaluated for treatment in the NCVHTC. Among them, 5517 patients received treatment by seven different DAA regimens with excellent results.

CONCLUSIONS: All regimens were highly effective at treating HCV in a real-life setting, apart from SOF/RBV, which was the least effective. A nationwide screening program and enhancing the follow-up of treated patients are the main missing pillars in the Egyptian model.

El Kassas, M., M. Alboraie, D. Omran, M. Salaheldin, M. N. Wifi, M. Elbadry, adel el tahan, S. Ezzat, E. Moaz, A. M. Farid, et al., "An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.", Expert review of gastroenterology & hepatology, pp. 1-8, 2018 May 24. Abstract

BACKGROUND: A large Egyptian treatment program for HCV was launched in2014 after the introduction of direct-acting antiviral agents (DAAs). This program depended mainly on establishing specialized independent centres for HCV treatment. These centres represent the major strengths in the Egyptian model of care, as they provide integrated care for HCV patients and have enabled Egypt to treat more than one million patients in 3 years. The New Cairo Viral Hepatitis Treatment Center (NCVHTC) is an example of these specialized centres.

METHODS: The Egyptian experience in the management of HCV was evaluated by analysing the data of real-life HCV management in the NCVHTC from 2014 to 2017. Results of different treatment regimens in addition to their strengths, limitations and areas for improvement are discussed in this report.

RESULTS: A total of 7042 HCV patients have been evaluated for treatment in the NCVHTC. Among them, 5517 patients received treatment by seven different DAA regimens with excellent results.

CONCLUSIONS: All regimens were highly effective at treating HCV in a real-life setting, apart from SOF/RBV, which was the least effective. A nationwide screening program and enhancing the follow-up of treated patients are the main missing pillars in the Egyptian model.

El Kassas, M., M. Alboraie, D. Omran, M. Salaheldin, M. N. Wifi, M. Elbadry, adel el tahan, S. Ezzat, E. Moaz, A. M. Farid, et al., "An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.", Expert review of gastroenterology & hepatology, pp. 1-8, 2018 May 24. Abstract

BACKGROUND: A large Egyptian treatment program for HCV was launched in2014 after the introduction of direct-acting antiviral agents (DAAs). This program depended mainly on establishing specialized independent centres for HCV treatment. These centres represent the major strengths in the Egyptian model of care, as they provide integrated care for HCV patients and have enabled Egypt to treat more than one million patients in 3 years. The New Cairo Viral Hepatitis Treatment Center (NCVHTC) is an example of these specialized centres.

METHODS: The Egyptian experience in the management of HCV was evaluated by analysing the data of real-life HCV management in the NCVHTC from 2014 to 2017. Results of different treatment regimens in addition to their strengths, limitations and areas for improvement are discussed in this report.

RESULTS: A total of 7042 HCV patients have been evaluated for treatment in the NCVHTC. Among them, 5517 patients received treatment by seven different DAA regimens with excellent results.

CONCLUSIONS: All regimens were highly effective at treating HCV in a real-life setting, apart from SOF/RBV, which was the least effective. A nationwide screening program and enhancing the follow-up of treated patients are the main missing pillars in the Egyptian model.

El Kassas, M., M. Alboraie, D. Omran, M. Salaheldin, M. N. Wifi, M. Elbadry, adel el tahan, S. Ezzat, E. Moaz, A. M. Farid, et al., "An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.", Expert review of gastroenterology & hepatology, vol. 12, issue 12, pp. 1265-1272, 2018. Abstract

BACKGROUND: A large Egyptian treatment program for HCV was launched in2014 after the introduction of direct-acting antiviral agents (DAAs). This program depended mainly on establishing specialized independent centres for HCV treatment. These centres represent the major strengths in the Egyptian model of care, as they provide integrated care for HCV patients and have enabled Egypt to treat more than one million patients in 3 years. The New Cairo Viral Hepatitis Treatment Center (NCVHTC) is an example of these specialized centres.

METHODS: The Egyptian experience in the management of HCV was evaluated by analysing the data of real-life HCV management in the NCVHTC from 2014 to 2017. Results of different treatment regimens in addition to their strengths, limitations and areas for improvement are discussed in this report.

RESULTS: A total of 7042 HCV patients have been evaluated for treatment in the NCVHTC. Among them, 5517 patients received treatment by seven different DAA regimens with excellent results.

CONCLUSIONS: All regimens were highly effective at treating HCV in a real-life setting, apart from SOF/RBV, which was the least effective. A nationwide screening program and enhancing the follow-up of treated patients are the main missing pillars in the Egyptian model.

A, K., S. H, A. T, and E. - S. M, "Accuracy of B-mode ultrasonography for diagnosingpregnancy and determination of fetal numbers in differentbreeds of goats", Anim Reprod Sci., vol. 147, pp. 25-31, 2014. Abstract

A total of 150 does of different breeds were used to evaluate the accuracy of transrectal (TRU) and transabdominal ultrasonography (TAU) for pregnancy diagnosis and fetal number estimation and to study the effect of breed and age of goats on the accuracy of ultrasonography. All does were scanned by TRU at days 17-22, 24-29 and 31-36 and by TAU at days 39-44 and 46-51 after breeding. The sensitivity (Se) of TRU for detecting pregnant does increased significantly (81.6% vs. 97.7%; P<0.0005) from days 17-22 to 24-29. There was a significant (P<0.05) effect of breed of goats on the specificity (Sp) of TAU for diagnosing non-pregnancy between days 39 and 51. In addition, there was a significant (P<0.01) effect of breed of goats on the Se and Sp of TRU for determination of does carrying multiples and singles, respectively, between days 24 and 36. The sensitivity of TAU for diagnosing pregnant does tended to be significantly (P=0.06) higher in young does (1.5-2 yr) than in older does (>2-9 yr) at days 39-44. The accuracy of TRU for determination of does carrying singles was significantly (P<0.05) higher in young does than that in older ones at days 24-29. In conclusions, TRU could be accurately used for early pregnancy diagnosis and fetal number estimation at days 24-29 and days 31-36, respectively, with accuracy similar to that of TAU at days 39-51. Furthermore, breed and age of does might influence the accuracy of ultrasonography for pregnancy diagnosis and fetal numbers estimation.

Eissa, O., R. Tabashy, S. Shoman, and M. Nadji, "Accuracy of MR Imaging in Diagnosis of Bone Invasion by Soft Tissue Sarcomas: Experience at NCI, Cairo, Egypt", Medical Journal of Cairo University, vol. 81, issue 2, pp. 39-49, 2013.
Abd El-Shafi, M. A., and M. H. Taha, "Accuracy of Predicting Phyllochron and Genetic Variability in Some Spring Bread Wheat Genotypes Affected by Temperature", Research Journal of Agriculture and Biological Sciences, vol. 10, issue 1, pp. 1-7, 2014. Abstract
n/a
Tawfik, W., "Accurate measurement of few-cycle laser pulses using SPIDER", Progress In Electromagnetics Research C, vol. 58: Electromagnetics Academy, pp. 135-142, 2015. AbstractWebsite

In this work, I report measuring the pulse duration of few-cycle pulses using spectral phase interferometry for direct electric-field reconstruction (SPIDER) with high accuracy. These few-cycle pulses were generated via self-phase modulation (SPM) in nonlinear medium (neon gas) in a one meter hollow-fiber followed by a pair of chirped mirrors performed the dispersion compensation. The observed reconstructed pulse intensity autocorrelation function varied from 5.35 fs to almost 13 fs. Moreover, the applied method allows for direct controlling of the pulse duration through variation of the chirping of input pulses at different pressure of neon gas. The observed results indicate that the SPM was enhanced for high neon pressure (2.5 atm.) and short input pluses (32 fs) without chirping. The obtained results may give an opportunity to monitor and control ultrafast transit interaction in femtosecond chemistry. © 2015, Electromagnetics Academy. All rights reserved.

Taher, A., M. S. Elalfy, K. A. Zir, S. Daar, A. A. Jefri, D. Habr, U. Kriemler-Krahn, A. El-Ali, B. Roubert, and A. El-Beshlawy, "Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with b-thalassaemia: results from the ESCALATOR study", European Journal of Haematology, vol. 87, pp. 349-354, 2011. AbstractCU-PDF

This analysis evaluated the effects of deferasirox on liver iron concentration in moderate and heavily iron-overloaded patients with ?-thalassaemia from the ESCALATOR trial (n = 231).

Taher, A., M. S. Elalfy, K. A. Zir, S. Daar, A. A. Jefri, D. Habr, U. Kriemler-Krahn, B. Roubert, and A. El-Beshlawy, "Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study.", European journal of haematology, vol. 87, issue 4, pp. 349-54, 2011 Oct. Abstract

This analysis evaluated the effects of deferasirox on liver iron concentration in moderate and heavily iron-overloaded patients with β-thalassaemia from the ESCALATOR trial (n = 231). Mean liver iron concentrations (LIC) decreased significantly from 21.1 ± 8.2 to 14.2 ± 12.1 mg Fe/g dry weight (dw) at 2 yr (P < 0.001) in patients with LIC ≥ 7 mg Fe/g dw at baseline; patients with LIC < 7 mg Fe/g dw maintained these levels over the treatment period. The proportion of patients with LIC < 7 mg Fe/g dw increased from 9.4% at core baseline to 39.3% by the end of year 2. The results showed that deferasirox enabled therapeutic goals to be achieved, by maintaining LIC in patients with LIC < 7 mg Fe/g dw at a mean dose of 22.4 ± 5.2 mg/kg/d and significantly reducing LIC in patients with LIC ≥ 7 mg Fe/g dw at a mean dose of 25.7 ± 4.2 mg/kg/d, along with a manageable safety profile.

Hani, H. A., S. R. Tewfik, M. H. Sorour, and N. Abdelmonem, "Acid washing of" Zeolite A": Performance assessment and optimization", J Am Sci, vol. 6, pp. 261–271, 2010. Abstract
n/a
Esmat, S., A. E. L. Tawdy, G. A. el aty Hafez, O. abu Zeid, D. abd el halim, M. A. Saleh, T. Leheta, and M. E. Mofty, "Acral lesions of vitiligo: why are they resistant to photochemotherapy?", Journal of European academy of Dermatology and Venereology, vol. September 26, issue 9, pp. 1097-1104, 2012.
Tourism